These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11731727)

  • 21. High frequency repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex in schizophrenic patients.
    Rollnik JD; Huber TJ; Mogk H; Siggelkow S; Kropp S; Dengler R; Emrich HM; Schneider U
    Neuroreport; 2000 Dec; 11(18):4013-5. PubMed ID: 11192620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidepressant efficacy of two different rTMS procedures. High frequency over left versus low frequency over right prefrontal cortex compared with sham stimulation.
    Höppner J; Schulz M; Irmisch G; Mau R; Schläfke D; Richter J
    Eur Arch Psychiatry Clin Neurosci; 2003 Apr; 253(2):103-9. PubMed ID: 12799750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive correlates of repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant depression--a pilot study.
    Kedzior KK; Rajput V; Price G; Lee J; Martin-Iverson M
    BMC Psychiatry; 2012 Oct; 12():163. PubMed ID: 23031294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive safety of dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression.
    Schulze L; Wheeler S; McAndrews MP; Solomon CJ; Giacobbe P; Downar J
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1213-26. PubMed ID: 27157074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized sham controlled trial of repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex for the treatment of panic disorder with comorbid major depression.
    Mantovani A; Aly M; Dagan Y; Allart A; Lisanby SH
    J Affect Disord; 2013 Jan; 144(1-2):153-9. PubMed ID: 22858212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.
    Rumi DO; Gattaz WF; Rigonatti SP; Rosa MA; Fregni F; Rosa MO; Mansur C; Myczkowski ML; Moreno RA; Marcolin MA
    Biol Psychiatry; 2005 Jan; 57(2):162-6. PubMed ID: 15652875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study.
    Cohen H; Kaplan Z; Kotler M; Kouperman I; Moisa R; Grisaru N
    Am J Psychiatry; 2004 Mar; 161(3):515-24. PubMed ID: 14992978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism.
    Kimbrell TA; Little JT; Dunn RT; Frye MA; Greenberg BD; Wassermann EM; Repella JD; Danielson AL; Willis MW; Benson BE; Speer AM; Osuch E; George MS; Post RM
    Biol Psychiatry; 1999 Dec; 46(12):1603-13. PubMed ID: 10624541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left prefrontal high-frequency repetitive transcranial magnetic stimulation for the treatment of schizophrenia with predominant negative symptoms: a sham-controlled, randomized multicenter trial.
    Wobrock T; Guse B; Cordes J; Wölwer W; Winterer G; Gaebel W; Langguth B; Landgrebe M; Eichhammer P; Frank E; Hajak G; Ohmann C; Verde PE; Rietschel M; Ahmed R; Honer WG; Malchow B; Schneider-Axmann T; Falkai P; Hasan A
    Biol Psychiatry; 2015 Jun; 77(11):979-88. PubMed ID: 25582269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repetitive transcranial magnetic stimulation (rTMS) improves facial affect recognition in schizophrenia.
    Wölwer W; Lowe A; Brinkmeyer J; Streit M; Habakuck M; Agelink MW; Mobascher A; Gaebel W; Cordes J
    Brain Stimul; 2014; 7(4):559-63. PubMed ID: 24857264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression.
    Pascual-Leone A; Rubio B; Pallardó F; Catalá MD
    Lancet; 1996 Jul; 348(9022):233-7. PubMed ID: 8684201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frontostriatal Connectivity Changes in Major Depressive Disorder After Repetitive Transcranial Magnetic Stimulation: A Randomized Sham-Controlled Study.
    Kang JI; Lee H; Jhung K; Kim KR; An SK; Yoon KJ; Kim SI; Namkoong K; Lee E
    J Clin Psychiatry; 2016 Sep; 77(9):e1137-e1143. PubMed ID: 27379563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antidepressant effects of high and low frequency repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex: a double-blind, randomized, placebo-controlled trial.
    Stern WM; Tormos JM; Press DZ; Pearlman C; Pascual-Leone A
    J Neuropsychiatry Clin Neurosci; 2007; 19(2):179-86. PubMed ID: 17431065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Add-on rTMS for treatment of depression: a pilot study using stereotaxic coil-navigation according to PET data.
    Herwig U; Lampe Y; Juengling FD; Wunderlich A; Walter H; Spitzer M; Schönfeldt-Lecuona C
    J Psychiatr Res; 2003; 37(4):267-75. PubMed ID: 12765849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive effects of treatment of depression with repetitive transcranial magnetic stimulation.
    Nadeau SE; Bowers D; Jones TL; Wu SS; Triggs WJ; Heilman KM
    Cogn Behav Neurol; 2014 Jun; 27(2):77-87. PubMed ID: 24968008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral blood flow ratio of the dorsolateral prefrontal cortex to the ventromedial prefrontal cortex as a potential predictor of treatment response to transcranial magnetic stimulation in depression.
    Kito S; Hasegawa T; Koga Y
    Brain Stimul; 2012 Oct; 5(4):547-53. PubMed ID: 22019081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive outcomes of TMS treatment in bipolar depression: Safety data from a randomized controlled trial.
    Myczkowski ML; Fernandes A; Moreno M; Valiengo L; Lafer B; Moreno RA; Padberg F; Gattaz W; Brunoni AR
    J Affect Disord; 2018 Aug; 235():20-26. PubMed ID: 29631203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial.
    George MS; Lisanby SH; Avery D; McDonald WM; Durkalski V; Pavlicova M; Anderson B; Nahas Z; Bulow P; Zarkowski P; Holtzheimer PE; Schwartz T; Sackeim HA
    Arch Gen Psychiatry; 2010 May; 67(5):507-16. PubMed ID: 20439832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression.
    Fitzgerald PB; Benitez J; de Castella A; Daskalakis ZJ; Brown TL; Kulkarni J
    Am J Psychiatry; 2006 Jan; 163(1):88-94. PubMed ID: 16390894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic efficacy of bilateral prefrontal slow repetitive transcranial magnetic stimulation in depressed patients with Parkinson's disease: an open study.
    Dragasevic N; Potrebić A; Damjanović A; Stefanova E; Kostić VS
    Mov Disord; 2002 May; 17(3):528-32. PubMed ID: 12112202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.